"Metabolic models predict fotemustine and the combination of ..."

Ali Kishk et al. (2024)

> Home

Details and statistics

DOI: 10.1093/BIB/BBAE199

access: closed

type: Journal Article

metadata version: 2025-08-10

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/bib/KishkPHS24
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bib/KishkPHS24
Ali Kishk, Maria Pires Pacheco, Tony Heurtaux, Thomas Sauter:
Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas. Briefings Bioinform. 25(3) (2024)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.